Beth Taylor - Net Worth and Insider Trading

Beth Taylor Net Worth

The estimated net worth of Beth Taylor is at least $2 Million dollars as of 2024-05-29. Beth Taylor is the VP Finance & Chief Acctg Offcr of Endocyte Inc and owns about 56,341 shares of Endocyte Inc (ECYT) stock worth over $1 Million. Beth Taylor is also the VP- Finance & CFO of Inotiv Inc and owns about 83,875 shares of Inotiv Inc (NOTV) stock worth over $176,976. Details can be seen in Beth Taylor's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Beth Taylor has not made any transactions after 2022-02-18 and currently still holds the listed stock(s).

Transaction Summary of Beth Taylor

To

Beth Taylor Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Beth Taylor owns 2 companies in total, including Inotiv Inc (NOTV) , and Endocyte Inc (ECYT) .

Click here to see the complete history of Beth Taylor’s form 4 insider trades.

Insider Ownership Summary of Beth Taylor

Ticker Comapny Transaction Date Type of Owner
NOTV Inotiv Inc 2023-01-18 Chief Financial Officer
ECYT Endocyte Inc 2018-12-21 VP Finance & Chief Acctg Off

Beth Taylor Latest Holdings Summary

Beth Taylor currently owns a total of 2 stocks. Among these stocks, Beth Taylor owns 56,341 shares of Endocyte Inc (ECYT) as of October 5, 2018, with a value of $1 Million and a weighting of 88.42%. Beth Taylor also owns 83,875 shares of Inotiv Inc (NOTV) as of February 18, 2022, with a value of $176,976 and a weighting of 11.58%.

Latest Holdings of Beth Taylor

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ECYT Endocyte Inc 2018-10-05 56,341 23.99 1,351,621
NOTV Inotiv Inc 2022-02-18 83,875 2.11 176,976

Holding Weightings of Beth Taylor


Beth Taylor Form 4 Trading Tracker

According to the SEC Form 4 filings, Beth Taylor has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the sale of 7,022 shares on October 5, 2018, which brought Beth Taylor around $109,262.

According to the SEC Form 4 filings, Beth Taylor has made a total of 3 transactions in Inotiv Inc (NOTV) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Inotiv Inc is the acquisition of 5,000 shares on February 18, 2022, which cost Beth Taylor around $115,350.

Insider Trading History of Beth Taylor

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Beth Taylor Trading Performance

GuruFocus tracks the stock performance after each of Beth Taylor's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Beth Taylor is 14.95%. GuruFocus also compares Beth Taylor's trading performance to market benchmark return within the same time period. The performance of stocks bought by Beth Taylor within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Beth Taylor's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Beth Taylor

Average Return

Average return per transaction

Outperforming Transactions

2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.95
Relative Return to S&P 500(%) 4.34

Beth Taylor Ownership Network

Ownership Network List of Beth Taylor

No Data

Ownership Network Relation of Beth Taylor


Beth Taylor Owned Company Details

What does Inotiv Inc do?

Who are the key executives at Inotiv Inc?

Beth Taylor is the Chief Financial Officer of Inotiv Inc. Other key executives at Inotiv Inc include Chief Operating Officer John Gregory Beattie , Chief Commercial Officer Michael Garrett , and SVP & Gen. Counsel & Secretary Andrea Castetter .

Inotiv Inc (NOTV) Insider Trades Summary

Over the past 18 months, Beth Taylor made no insider transaction in Inotiv Inc (NOTV). Other recent insider transactions involving Inotiv Inc (NOTV) include a net purchase of 47,966 shares made by John Gregory Beattie , a net purchase of 5,100 shares made by John E Sagartz , and a net purchase of 5,000 shares made by Michael Garrett .

In summary, during the past 3 months, insiders sold 0 shares of Inotiv Inc (NOTV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,123 shares of Inotiv Inc (NOTV) were sold and 58,066 shares were bought by its insiders, resulting in a net purchase of 54,943 shares.

Inotiv Inc (NOTV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inotiv Inc Insider Transactions

No Available Data

Beth Taylor Mailing Address

Above is the net worth, insider trading, and ownership report for Beth Taylor. You might contact Beth Taylor via mailing address: 3000 Kent Avenue, Suite A1-100, West Lafayette In 47906.

Discussions on Beth Taylor

No discussions yet.